NEW YORK--(BUSINESS WIRE)--Ovid Therapeutics Inc. (Ovid), a privately held biopharmaceutical company focused on developing therapies for rare and orphan diseases of the brain, today announced that Douglas E. Williams, Ph.D., has joined the Company’s Board of Directors, effective immediately. Dr. Williams, the founding Chief Executive Officer of Codiak Biosciences and former Executive Vice President, Research and Development at Biogen, possesses more than 25 years of scientific and senior leadership experience within the life sciences industry.
